原发性肝癌TACE治疗后的影像学评价  

Imaging evaluation of transcatheter arterial chemoembolization in treating hepatocellular carcinomas

作　　者：聂德红 邵建民[2] 李洪义[3] 张启暝 黄小飞[1] 

机构地区：[1]广东省中山市黄圃人民医院放射线科,广东中山528429 [2]河南省漯河医学高等专科学校,河南漯河462002 [3]哈尔滨医科大学附属肿瘤医院介入科,哈尔滨150000

出　　处：《中国当代医药》2015年第18期17-20,共4页China Modern Medicine

摘　　要：原发性肝癌是严重威胁人类健康及寿命的恶性肿瘤之一,经动脉导管化疗栓塞术(TACE)是治疗原发性肝癌应用较为广泛的非外科手术治疗方法,准确地判断肝癌TACE治疗术后的疗效直接关系到临床治疗方案的选择及预后。目前,临床上对肝癌TACE术后的影像学检查方法众多,本文主要针对超声、CT、MR、DSA及PET/CT等影像学检查方法在肝癌TACE治疗后疗效评估中应用的现状进行综述。Primary hepatic carcinoma is one of the serious diseases that threaten human beings′ health and life.Transarterial chemoembolization（TACE） has become a nonsurgical treatment now widely and commonly used in the clinical practice.Correctly assessing the therapeutic efficacy of TACE for primary hepatic carcinoma is clinically very important as the judgment is directly related to the reasonable selection of therapeutic scheme as well as to the precise expectation of the prognosis.Nowadays,there are many different imaging methods to make assessment of the therapeutic response of TACE for primary hepatic carcinoma.This article mainly describes the applications of different imaging methodsl,focusing on ultrasonography,CT,MRI,DSA and PET/CT in clinical evaluation of the therapeutic efficacy of TACE for the primary hepatic carcinoma,and the current situation of this technique will also be briefly discussed.

关 键 词：原发性肝癌 经动脉导管化疗栓塞术 超声 CT MRI DSA PET/CT 

分 类 号：R735.7[医药卫生—肿瘤]